1. Key Insights

2. Organizations

3. Executive summary

4. Epidemiology Methodology

5. Prosthetic joint infection (PJI): Patient Overview at a Glance
5.1. Total Patient Share (%) Distribution of Prosthetic joint infection (PJI) in 2017
5.2. Total Patient Share (%) Distribution of Prosthetic joint infection (PJI) in 2030

6. Overview
6.1. Introduction
6.2. Signs and Symptoms
6.3. Risk Factors
6.4. Pathogenesis
6.5. Causative Microorganisms
6.6. Classification
6.7. Diagnosis
6.7.1. Diagnostic Guidelines
6.7.2. Biologics and Biomarkers in the Treatment and Diagnosis of Prosthetic Joint Infection

7. Epidemiology and Patient Population
7.1. Key Findings
7.2. Total cases of Prosthetic joint infection (PJI) in 7MM

8. Country Wise-Epidemiology of Prosthetic Joint Infection
8.1. Country Wise-Epidemiology of Prosthetic Joint Infection
8.2. United States
8.2.1. Assumptions and Rationale
8.2.2. Total number of Arthroplasty in the United States
8.2.3. Total Prosthetic joint infection (PJI) cases in the US
8.2.4. Gender-Specific cases of Prosthetic Joint Infection in the United States
8.2.5. Causative Microorganism-specific cases of Prosthetic joint infection (PJI) in the United States
8.3. EU5 Countries
8.4. Germany
8.4.1. Assumptions and Rationale
8.4.2. Total number of Arthroplasty in Germany
8.4.3. Total Prosthetic joint infection (PJI) cases in Germany
8.4.4. Gender-Specific cases of Prosthetic Joint Infection in Germany
8.4.5. Causative Microorganism-specific cases of Prosthetic joint infection (PJI) in Germany
8.5. France
8.5.1. Assumptions and Rationale
8.5.2. Total number of Arthroplasty in France
8.5.3. Total Prosthetic joint infection (PJI) cases in France
8.5.4. Gender-Specific cases of Prosthetic Joint Infection in France
8.5.5. Causative Microorganism-specific cases of Prosthetic joint infection (PJI) France
8.6. Italy
8.6.1. Assumptions and Rationale
8.6.2. Total number of Arthroplasty in Italy
8.6.3. Total Prosthetic joint infection (PJI) cases in Italy
8.6.4. Gender-Specific cases of Prosthetic Joint Infection in Italy
8.6.5. Causative Microorganism-specific cases of Prosthetic joint infection (PJI) in Italy
8.7. Spain
8.7.1. Assumptions and Rationale
8.7.2. Total Number of Arthroplasty in Spain
8.7.3. Total Prosthetic joint infection (PJI) cases in Spain
8.7.4. Gender-Specific cases of Prosthetic Joint Infection in Spain
8.7.5. Causative Microorganism-specific cases of Prosthetic joint infection (PJI) Spain
8.8. UK
8.8.1. Assumptions and Rationale
8.8.2. Total Number of Arthroplasty in the United Kingdom
8.8.3. Total Prosthetic joint infection (PJI) cases in the United Kingdom
8.8.4. Gender-Specific cases of Prosthetic Joint Infection in the United Kingdom
8.8.5. Causative Microorganism-specific cases of Prosthetic joint infection (PJI) in the United Kingdom
8.9. Japan
8.9.1. Assumptions and Rationale
8.9.2. Total number of Arthroplasty in Japan
8.9.3. Total Prosthetic joint infection (PJI) cases in Japan
8.9.4. Gender-Specific cases of Prosthetic Joint Infection in Japan
8.9.5. Causative Microorganism-specific cases of Prosthetic joint infection (PJI) in Japan

9. KOL Views

10. Bibliography

11. Appendix
11.1. Report Methodology

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Tables
Table 1: Key organizations of PJI
Table 2: Classifications of prosthetic joint infections (PJI)
Table 3: Prosthetic joint infections: clinical management, diagnosis, and treatment
Table 4: Proposed definitions for prosthetic joint infection
Table 5: Total cases of Prosthetic joint infection (PJI) in 7MM (2017–2030)
Table 6: Total number of Arthroplasty in the United States (2017–2030)
Table 7: Total Prosthetic Joint Infection cases in the US (2017–2030)
Table 8: Gender-specific cases of Prosthetic Joint Infection in the US (2017–2030)
Table 9: Causative Microorganism-specific cases of Prosthetic Joint Infection in the US (2017–2030)
Table 10: Total number of Arthroplasty in Germany (2017–2030)
Table 11: Total Prosthetic Joint Infection cases in Germany (2017–2030)
Table 12: Gender-specific cases of Prosthetic Joint Infection in Germany (2017–2030)
Table 13: Causative Microorganism-specific cases of Prosthetic Joint Infection in Germany (2017–2030)
Table 14: Total number of Arthroplasty in France (2017–2030)
Table 15: Total Prosthetic Joint Infection cases in France (2017–2030)
Table 16: Gender-specific cases of Prosthetic Joint Infection in France (2017–2030)
Table 17: Causative Microorganism-specific cases of Prosthetic Joint Infection in France (2017–2030)
Table 18: Total number of Arthroplasty in Italy (2017–2030)
Table 19: Total Prosthetic Joint Infection cases in Italy (2017–2030)
Table 20: Gender-specific cases of Prosthetic Joint Infection in Italy (2017–2030)
Table 21: Causative Microorganism-specific cases of Prosthetic Joint Infection in Italy (2017–2030)
Table 22: Total Number of Arthroplasty in Spain (2017–2030)
Table 23: Total Prosthetic Joint Infection cases in Germany (2017–2030)
Table 24: Gender-specific cases of Prosthetic Joint Infection in Spain (2017–2030)
Table 25: Causative Microorganism-specific cases of Prosthetic Joint Infection in Spain (2017–2030)
Table 26: Total Number of Arthroplasty in the United Kingdom (2017–2030)
Table 27: Total Prosthetic Joint Infection cases in the UK (2017–2030)
Table 28: Gender-specific cases of Prosthetic Joint Infection in the UK (2017–2030)
Table 29: Causative Microorganism-specific cases of Prosthetic Joint Infection in UK (2017–2030)
Table 30: Total number of Arthroplasty in Japan (2017–2030)
Table 31: Total Prosthetic Joint Infection cases in Japan (2017–2030)
Table 32: Gender-specific cases of Prosthetic Joint Infection in Japan (2017–2030)
Table 33: Causative Microorganism-specific cases of Prosthetic Joint Infection in Japan (2017–2030)

List of Figures
Figure 1: Epidemiology Methodology
Figure 2: Signs and Symptoms for PJI
Figure 3: Risk factors for PJI
Figure 4: Pathogen that causes septic arthritis and prosthetic joint Infection
Figure 5: Preoperative and intraoperative diagnosis of prosthetic joint infection
Figure 6: Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Figure 7: Total cases of Prosthetic joint infection (PJI) in 7MM (2017–2030)
Figure 8: Total number of Arthroplasty in the United States (2017–2030)
Figure 9: Total Prosthetic Joint Infection cases in the US (2017–2030)
Figure 10: Gender-Specific cases of Prosthetic Joint Infection in the US (2017–2030)
Figure 11: Causative Microorganism-specific cases of Prosthetic Joint Infection in the US (2017–2030)
Figure 12: Total number of Arthroplasty in Germany (2017–2030)
Figure 13: Total Prosthetic Joint Infection cases in Germany (2017–2030)
Figure 14: Gender-Specific cases of Prosthetic Joint Infection in Germany (2017–2030)
Figure 15: Causative Microorganism-specific cases of Prosthetic Joint Infection in Germany (2017–2030)
Figure 16: Total number of Arthroplasty in France (2017–2030)
Figure 17: Total Prosthetic Joint Infection cases in France (2017–2030)
Figure 18: Gender-Specific cases of Prosthetic Joint Infection in France (2017–2030)
Figure 19: Causative Microorganism-specific cases of Prosthetic Joint Infection in France (2017–2030)
Figure 20: Total number of Arthroplasty in Italy (2017–2030)
Figure 21: Total Prosthetic Joint Infection cases in Italy (2017–2030)
Figure 22: Gender-Specific cases of Prosthetic Joint Infection in Italy (2017–2030)
Figure 23: Causative Microorganism-specific cases of Prosthetic Joint Infection in Italy (2017–2030)
Figure 24: Total Number of Arthroplasty in Spain (2017–2030)
Figure 25: Total Prosthetic Joint Infection cases in Germany (2017–2030)
Figure 26: Gender-Specific cases of Prosthetic Joint Infection in Spain (2017–2030)
Figure 27: Causative Microorganism-specific cases of Prosthetic Joint Infection in Spain (2017–2030)
Figure 28: Total Number of Arthroplasty in the United Kingdom (2017–2030)
Figure 29: Total Prosthetic Joint Infection cases in the UK (2017–2030)
Figure 30: Gender-Specific cases of Prosthetic Joint Infection in the UK (2017–2030)
Figure 31: Causative Microorganism-specific cases of Prosthetic Joint Infection in the UK (2017–2030)
Figure 32: Total number of Arthroplasty in Japan (2017–2030)
Figure 33: Total Prosthetic Joint Infection cases in Japan (2017–2030)
Figure 34: Gender-Specific cases of Prosthetic Joint Infection in Japan (2017–2030)
Figure 35: Causative Microorganism-specific cases of Prosthetic Joint Infection in Japan (2017–2030)